W

e suspect we’re not the only ones who find it challenging to keep up with the many experiments that are CRISPR’ing seemingly every disease under the sun in mice, human cells, and other experimental systems, even human embryos. So we’re doing it for you: STAT has created a searchable CRISPR Trackr.

It lists studies from research journals, company announcements, and preprints, chosen because they reported a key advance in either the genome-editing technology or the diseases that might be treated with it. It also links to the research papers, though not all are open access (sorry). We’re not including everything, but we hope CRISPR Trackr gives you a sense of how quickly things are moving. We’ll update it as needed.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.